{"database": "lobbying", "table": "lobbying_activities", "rows": [[1001432, "65da2f63-b859-4ce3-b900-e77bcb08476a", "Q3", "TARPLIN, DOWNS & YOUNG, LLC", 304736, "ASTRAZENECA", 2010, "third_quarter", "HCR", "**see addendum page S. 301/H.R. 3138  Physician Payments Sunshine Act of 2009, disclosure\n\nBiosimilars\n     S. 726/H.R. 1427  Access to Life-Saving Medicine Act, Follow-on Biologics\n     H.R. 1548  The Pathway for Biosimilars Act\n\nPL 111-148  The Patient Protection and Affordable Care Act, implementation, health care reform, drug importation, follow-on biologics, 340b, comparative effectiveness, gift disclosure, Medicaid and Medicare reimbursement", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2010-10-19T10:58:05.333000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1001432"], "units": {}, "query_ms": 0.3801820566877723, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}